Package insert. Col Benemid. West Point, PA: Merck Sharp & Dohme, December 1979.
2.
Analgesic agents: agents for gout. In: BoydJR ed. Facts and comparisons. St. Louis: JB Lippincott, 1986:255–5c.
3.
PascualeLrDubinABronskyDHoffmanWs. Inhibition of the uricosuric action of benemid by salicylate. J Lab Clin Med1955; 45: 771–7.
4.
KochPaSchultzLaWillsRj HALLQUIST St., WELLING PG. Influence of food and fluid ingestion on aspirin bioavailability. J Pharm Sci1978; 67: 1533–5.
5.
BrooksCdUlrichJe. Effect of ibuprofen or aspirin on probenecid-induced uricosuria. J Int Med Res1980; 5: 283–5.
6.
KersleyGcCookerRrToveyDcj. Value of uricosuric agents and in particular of G.28 315 in gout. Ann Rheum Dis1958; 77: 326–33.
7.
SeegmillerJe, GrayzelAl Use of the newer uricosuric agents in the management of gout. JAMA1960; 773: 106–10.
8.
BaberNHallidayL. SibeonRLittlerT ORME ML. The interaction between indomethacin and probenecid. A clinical and pharmacokinetic study. Clin Pharmacol Ther1978; 24: 298–307.
9.
YutfPerelj. Pharmacokinetic and clinical studies of carprofen in gout. J Clin Pharmacol1980; 3: 347–51.
10.
RunkelRMroszczakEChaplinMSevel1UsH SEGRE E. Naproxen-probenecid interaction. Clin Pharmacol Ther1978; 24: 706–13.
11.
WallerEs. The effect of probenecid on the disposition of meclofenamate sodium (abstract). Drug Intell Clin Pharm1983; 77: 453–4.
12.
UptonRa. Williams Rl. Buskin Jn. Effects of probenecid on ketoprofen kinetics. CHn Pharmacol Ther1982; 37: 705–12.
13.
LorenzRl. Weber MKotzurJSchackyCv. Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily): effects on platelet aggregation and thromboxane formation. Lancet1984; 7: 1261–4.